| Literature DB >> 34032757 |
Zhigang Xie1, Sandhya Yadav1, Samantha A Larson1, Arch G Mainous1,2, Young-Rock Hong1.
Abstract
ABSTRACT: In efforts to improve the delivery of quality primary care, patient-centered medical home (PCMH) model has been promoted. However, evidence on its association with health outcomes has been mixed. The aim of this study was to assess the performance of PCMH model on quality of care, patient experience, health expenditures.This was a cross-sectional study of the 2015-2016 Medical Expenditure Panel Survey-Medical Organization Survey linked data, including 5748 patient-provider pairs. We examined twenty-four quality of care measures (18 high-value and 6 low-value care services), health service utilization, patient experience (patient-provider communication, satisfaction), and health expenditure.Of 5748 patients, representing a weighted population of 56.2 million American adults aged 18 years and older, 44.2% were cared for by PCMH certified providers. 9.3% of those with PCMHs had at least one inpatient stay in the past year, which was comparable to the 11.4% among those with non-PCMHs. Similarly, 17.4% of respondents cared for by PCMH and 18.5% cared for by non-PCMH had at least one ED visit. Overall, we found no significant differences in quality of care measures (neither high-nor low-value of care) between the two groups. The overall satisfaction, the experience of access to care, and communication with providers were also comparable. Patients who were cared for by PCMHs had less total health expenditure (difference $217) and out-of-pocket spending (difference $91) than those cared for by non-PCMHs; however, none of these differences reached the statistical significance (adjusted P > 0.05 for all).This study found no meaningful difference in quality of care, patient experience, health care utilization, or health care expenditures between respondents cared for by PCMH and non-PCMH. Our findings suggest that the PCMH model is not superior in the quality of care delivered to non-PCMH providers.Entities:
Mesh:
Year: 2021 PMID: 34032757 PMCID: PMC8154504 DOI: 10.1097/MD.0000000000026119
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.889
Characteristics of respondents and paired certified-PCMH versus non-PCMH providers.
| Characteristics | PCMHEstimates % (95% CI)∗ | Non-PCMHEstimates % (95% CI)∗ | |
| Sample, n | 2540 | 3208 | |
| Weighted, n | 24,809,532 | 31,405,634 | |
| Age, y | .56 | ||
| 18–49 | 37.7 (34.0–41.3) | 37.3 (34.0–40.6) | |
| 50–64 | 32.1 (28.6–35.6) | 30.3 (27.2–33.3) | |
| 65 + | 30.2 (26.4–34.0) | 32.4 (29.3–35.6) | |
| Sex | .02 | ||
| Female | 40.0 (37.3–42.6) | 44.3 (42.2–46.5) | |
| Race/ethnicity | .91 | ||
| Non-Hispanic White | 71.9 (68.3–75.5) | 70.4 (67.2–73.6) | |
| Non-Hispanic Black | 8.9 (7.0–10.7) | 9.3 (7.5–11.2) | |
| Hispanic | 11.8 (8.9–14.7) | 12.3 (10.2–14.4) | |
| Other | 7.4 (5.5–9.3) | 8.0 (6.3–9.6) | |
| Family income level | .90 | ||
| Low income (<200% FPL) | 27.5 (24.0–31.1) | 26.6 (23.1–30.1) | |
| Middle income (200%–400% FPL) | 26.4 (23.6–29.2) | 27.1 (24.2–29.9) | |
| High income (>400% FPL) | 46.1 (41.8–50.3) | 46.3 (42.5–50.2) | |
| Education | .92 | ||
| Less than high school | 4.7 (3.5–6.0) | 4.9 (4.0–5.8) | |
| High school diploma or GED | 37.1 (33.8–40.5) | 36.7 (33.6–39.8) | |
| Some college education | 20.5 (17.8–23.3) | 19.5 (17.0–21.9) | |
| College and above | 37.6 (34.1–41.1) | 38.9 (35.5–42.4) | |
| Marital status | .88 | ||
| Married | 56.6 (52.8–60.5) | 56.2 (53.0–59.5) | |
| Employment | .51 | ||
| Employed | 57.8 (54.1–61.5) | 56.3 (53.3–59.4) | |
| Insurance status | .12 | ||
| Any private | 69.7 (66.5–72.8) | 70.6 (67.6–73.7) | |
| Any public | 25.8 (22.8–28.7) | 26.2 (23.2–29.2) | |
| Not insured | 4.6 (3.5–5.7) | 3.1 (2.3–4.0) | |
| Current smoking | .57 | ||
| Yes | 13.8 (12.0–15.5) | 13.1 (11.4–14.8) | |
| Obese (BMI ≥30) | .03 | ||
| Yes | 33.2 (30.2–36.3) | 37.5 (34.7–40.3) | |
| Self-reported health status | .92 | ||
| Fair/poor | 18.2 (15.5–20.8) | 18.0 (15.9–20.0) | |
| No. of Comorbidity | .21 | ||
| 0 | 32.9 (29.8–36.0) | 32.7 (29.7–35.7) | |
| 1 | 28.4 (25.6–31.3) | 25.2 (23.1–27.3) | |
| 2 | 20.4 (18.0–22.7) | 23.2 (20.8–25.5) | |
| 3 + | 18.3 (15.4–21.1) | 18.9 (16.8–21.1) | |
| Type of practice | <.001 | ||
| Independent practice | 47.5 (43.3–51.6) | 64.9 (60.5–69.3) | |
| Physician network | 23.4 (19.5–27.3) | 18.1 (13.8–22.4) | |
| Nonprofit and government clinics | 17.6 (14.3–20.9) | 7.8 (6.0–9.6) | |
| Others | 11.6 (8.4–14.7) | 9.2 (7.1–11.4) | |
| No. of primary physicians | <.001 | ||
| ≤1 | 19.2 (15.9–22.4) | 40.7 (35.8–45.7) | |
| 2–5 | 41.8 (37.1–46.5) | 36.7 (32.3–41.2) | |
| 6–10 | 16.5 (13.3–19.7) | 11.2 (7.6–14.8) | |
| ≥11 | 22.5 (18.7–26.3) | 11.4 (8.2–14.5) | |
| No. of nurse practitioners/physician assistants | <.001 | ||
| 0 | 22.1 (18.8–25.4) | 30.0 (25.9–34.1) | |
| 1 | 19.1 (15.1–23.1) | 25.5 (21.2–29.8) | |
| 2–3 | 27.4 (24.0–30.7) | 22.0 (18.8–25.2) | |
| ≥4 | 31.5 (27.0–35.9) | 22.5 (18.0–27.0) | |
| Having capitated contracts | <.001 | ||
| Yes | 56.8 (52.1–61.5) | 36.3 (32.7–39.9) | |
| Percentage of Medicaid patients | <.001 | ||
| <10% | 32.8 (28.4–37.2) | 48.6 (44.2–52.9) | |
| 10%–50% | 48.6 (44.0–53.3) | 38.1 (33.3–43.0) | |
| >50% | 18.6 (15.8–21.4) | 13.3 (10.3–16.2) |
Adjusted Differences in high-value and low-value primary care for respondents aged 18 years and older cared for by certified PCMH and non-PCMH providers.
| PCMH | Non-PCMH | ||||||
| Type of primary care∗ | No. | Estimates % (95% CI) | No. | Estimates % (95% CI) | Difference, % (95% CI)† | Adjusted§ | |
| Diabetes care composite | 440 | 81.4 (75.1–87.7) | 627 | 83.2 (78.6–87.7) | −1.8 (−10.0 to 6.5) | .67 | .90 |
| HbA1c | 440 | 55.5 (47.8–63.1) | 627 | 54.7 (48.5–61.0) | 0.7 (−10.0 to 11.4) | .90 | .90 |
| Foot examination | 440 | 68.6 (61.7–75.4) | 627 | 65.5 (59.2–71.8) | 3.1 (−7.2 to 13.3) | .56 | .90 |
| Eye examination | 440 | 62.3 (56.3–68.4) | 627 | 61.5 (55.6–67.4) | 0.8 (−8.1 to 9.8) | .86 | .90 |
| Cancer screening composite | 1795 | 77.5 (73.7–81.4) | 2195 | 76.9 (74.1–79.6) | 0.6 (−4.0 to 5.3) | .79 | .90 |
| Cervical cancer Screening | 932 | 86.4 (82.3–90.4) | 1042 | 86.9 (83.5–90.2) | −0.5 (−5.8 to 4.8) | .85 | .90 |
| Breast cancer Screening | 668 | 81.6 (76.3–86.9) | 820 | 81.1 (77.1–85.2) | 0.5 (−6.6 to 7.5) | .90 | .90 |
| Colorectal cancer Screening | 1200 | 73.9 (69.1–78.7) | 1531 | 72.6 (69.1–76.1) | 1.3 (−4.5 to 7.0) | .67 | .90 |
| Diagnostic and preventive testing/care composite | 2540 | 98.2 (97.6–98.8) | 3208 | 97.0 (96.2–97.9) | 1.1 (0.1 to 2.2) | .03 | .46 |
| Cholesterol measurement | 2061 | 98.2 (97.6–98.8) | 2656 | 96.7 (95.7–97.7) | 1.5 (0.3 to 2.6) | .01 | .40 |
| Blood pressure measurement | 2540 | 99.3 (98.8–99.7) | 3208 | 98.8 (98.4–99.2) | 0.5 (−0.1 to 1.0) | .14 | .72 |
| Influenza vaccine | 2540 | 57.0 (53.6–60.4) | 3208 | 54.8 (51.7–57.9) | 2.2 (−2.2 to 6.7) | .33 | .85 |
| Routine checkup | 2540 | 87.7 (85.5–90.0) | 3208 | 87.2 (85.4–89.0) | 0.5 (−2.2 to 3.2) | .71 | .90 |
| Dental checkup | 2340 | 47.6 (43.7–51.6) | 2929 | 46.8 (43.2–50.5) | 0.8 (−4.5 to 6.0) | .78 | .90 |
| Counseling composite | 1918 | 67.2 (64.2–70.1) | 2440 | 65.0 (62.2–67.8) | 2.2 (−1.9 to 6.4) | .30 | .84 |
| Exercise counseling | 1788 | 65.4 (62.0–68.7) | 2306 | 63.7 (60.9–66.5) | 1.7 (−2.7 to 6.1) | .46 | .90 |
| Smoking cessation counseling | 358 | 75.9 (67.7–84.1) | 442 | 74.0 (67.9–80.1) | 2.0 (−8.2 to 12.1) | .71 | .90 |
| Medical treatment composite | 985 | 32.2 (27.2–37.2) | 1369 | 36.7 (31.0–42.3) | −4.4 (−12.2 to 3.3) | .26 | .84 |
| Anticoagulation for atrial fibrillation | 116 | 49.5 (38.8–60.1) | 150 | 60.8 (51.3–70.4) | −11.4 (−25.1 to 2.3) | .10 | .80 |
| Salicylates and/or platelet aggregation inhibitors for CAD/MI | 452 | 14.6 (8.9–20.2) | 637 | 13.4 (7.7–19.2) | 1.1 (−7.0 to 9.2) | .79 | .90 |
| Beta blocker for CAD/MI | 452 | 59.3 (51.6–67.0) | 637 | 67.7 (60.5–74.9) | −8.4 (−19.3 to 2.4) | .13 | .79 |
| ACEi/ARB for diabetes & hypertension | 489 | 64.3 (56.6–72.0) | 721 | 63.2 (56.4–70.0) | 1.1 (−8.9 to 11.2) | .83 | .90 |
| Antiplatelet for CVA | 164 | 17.4 (10.0–24.8) | 224 | 28.4 (19.8–36.9) | −11.0 (−21.6 to −0.3) | .04 | .46 |
| Cancer screening composite | 470 | 47.1 (40.1–54.2) | 713 | 42 (36.2–47.9) | 5.1 (−4.1 to 14.4) | .28 | .84 |
| Cervical cancer screening in women aged 65 + | 384 | 42.2 (34.4–50.0) | 544 | 38.1 (32.1–44.2) | 4.1 (−5.7 to 13.8) | .41 | .90 |
| Colorectal cancer screening in adults aged 75 + | 260 | 22.5 (14.3–30.6) | 414 | 17.7 (12.4–22.9) | 4.8 (−3.8 to 13.4) | .27 | .84 |
| Prostate cancer screening in men aged 75 + | 86 | 33.9 (21.6–46.2) | 169 | 37.9 (28.6–47.2) | −4 (−20.4 to 12.4) | .63 | .90 |
| Medical treatment composite | 1501 | 11.2 (8.8–13.5) | 2048 | 12.4 (10.1–14.6) | −1.2 (−4.4 to 2.0) | .46 | .90 |
| Anxiolytics/sedatives/ hypnotics in adults 65 + | 834 | 7.6 (5.1–10.1) | 1219 | 8.8 (6.6–11.1) | −1.2 (−4.8 to 2.3) | .50 | .90 |
| Benzodiazepine for depression | 273 | 21.3 (15.2–27.3) | 346 | 25.8 (19.4–32.1) | −4.5 (−12.8 to 3.9) | .29 | .84 |
| NSAID use for hypertension/heart failure/kidney disease | 908 | 10.1 (6.9–13.2) | 1208 | 10.8 (8.1–13.6) | −0.8 (−4.9 to 3.3) | .71 | .90 |
Adjusted differences in patient experience for respondents aged 18 years and older cared for by certified PCMH and non-PCMH providers.
| PCMH | Non-PCMH | ||||||
| Patient experience | No. | Estimates %(95% CI) | No. | Estimates %(95% CI) | Difference %(95% CI)∗ | Adjusted‡ | |
| Overall satisfaction | 2140 | 82.1 (79.4–84.8) | 2690 | 81.6 (79.6–83.6) | 0.5 (−3.0 to 3.9) | .80 | .90 |
| Access composite | 2203 | 78.0 (75.4–80.6) | 2813 | 78.4 (76.2–80.6) | −0.4 (−3.9 to 3.1) | .82 | .90 |
| Got care right away | 762 | 66.4 (60.7–72.2) | 1072 | 71.3 (67.7–74.9) | −4.9 (−12.1 to 2.4) | .19 | .77 |
| Got needed appointment | 1983 | 60.7 (57.1–64.3) | 2482 | 60.8 (57.7–64.0) | −0.2 (−4.9 to 4.6) | .95 | .95 |
| Easy to get care | 1561 | 71.9 (68.7–75.1) | 2032 | 69.0 (65.9–72.1) | 2.9 (−1.7 to 7.5) | .21 | .77 |
| Easy to see specialist | 1112 | 51.9 (47.3–56.4) | 1437 | 59.2 (55.4–63.0) | −7.3 (−13.5 to −11.5) | .02 | .22 |
| Communication composite | 2162 | 80.4 (77.5–83.2) | 2719 | 81.6 (79.3–84.0) | −1.2 (−5.0 to 2.6) | .52 | .90 |
| Listened carefully | 2141 | 66.8 (63.2–70.5) | 2698 | 67.5 (64.7–70.3) | −0.6 (−5.6 to 4.3) | .80 | .90 |
| Showed respect | 2154 | 70.1 (67.2–73.1) | 2710 | 72.4 (69.7–75.0) | −2.2 (−6.4 to1.9) | .29 | .80 |
| Spent enough time | 2156 | 58.4 (54.6–62.2) | 2708 | 59.4 (56.4–62.5) | −1.0 (−5.8 to 3.7) | .67 | .90 |
| Explained easily | 2156 | 65.5 (62.3–68.7) | 2713 | 67.6 (64.6–70.6) | −2.1 (−6.7 to 2.5) | .38 | .83 |
Figure 1Adjusted health care utilization for respondents aged 18 years and older cared by certified PCMH and non-PCMH providers. Materials and methods: Multivariate logistic regression models adjusting for sex, obesity, practice type, the number of physicians, the number of non-physicians, capitation contract, and the percentage of Medicaid patients. Results: 9.3% of those with PCMHs had at least one inpatient stay in the past year, which was comparable to the 11.4% among those with non-PCMHs. Similarly, 17.4% of respondents cared for by PCMH and 18.5% cared for by non-PCMH had at least one ED visits. Definitions: Blue, respondents cared for by patient-centered medical home (PCMH); orange, respondents cared for by non-PCMH.
Figure 2Adjusted differences in health care expenditures for respondents aged 18 years and older cared for by certified PCMH and non-PCMH providers. Materials and methods: Generalized linear models (GLMs) with log link and gamma distribution, adjusting for all patient characteristics. Results: The annual total health care expenditures for those cared for by PCMH were $9050, whereas the amount for those cared for by non-PCMH providers was $9266. Respondents cared for by PCMH and non-PCMH providers had $816 and $892 out-of-pocket spending, respectively. Definitions: Blue, respondents cared for by patient-centered medical home (PCMH); orange, respondents cared for by non-PCMH.